TPO and rheumatoid arthritis: Recently, strategies that avoid glucocorticoid side effects have been favored, and a strong emphasis has been placed on shared decision-making, especially regarding second-line therapy, including the early administration of thrombopoietin receptor agonist (TPO-RA) [8].